rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1995-11-21
|
pubmed:abstractText |
We determined whether the addition of topical apraclonidine hydrochloride to eyes that are receiving maximal medical therapy but still have inadequate intraocular pressure control and that are scheduled to undergo surgery could adequately decrease intraocular pressure, postponing the need for further intervention.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0002-9394
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
120
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
423-32
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7573299-Adrenergic alpha-Agonists,
pubmed-meshheading:7573299-Adrenergic beta-Antagonists,
pubmed-meshheading:7573299-Adult,
pubmed-meshheading:7573299-Aged,
pubmed-meshheading:7573299-Aged, 80 and over,
pubmed-meshheading:7573299-Carbonic Anhydrase Inhibitors,
pubmed-meshheading:7573299-Clonidine,
pubmed-meshheading:7573299-Double-Blind Method,
pubmed-meshheading:7573299-Drug Therapy, Combination,
pubmed-meshheading:7573299-Female,
pubmed-meshheading:7573299-Glaucoma, Open-Angle,
pubmed-meshheading:7573299-Humans,
pubmed-meshheading:7573299-Intraocular Pressure,
pubmed-meshheading:7573299-Male,
pubmed-meshheading:7573299-Middle Aged,
pubmed-meshheading:7573299-Miotics,
pubmed-meshheading:7573299-Ophthalmic Solutions,
pubmed-meshheading:7573299-Prospective Studies,
pubmed-meshheading:7573299-Sympathomimetics,
pubmed-meshheading:7573299-Treatment Outcome
|
pubmed:year |
1995
|
pubmed:articleTitle |
Short-term efficacy of apraclonidine hydrochloride added to maximum-tolerated medical therapy for glaucoma. Apraclonidine Maximum-Tolerated Medical Therapy Study Group.
|
pubmed:affiliation |
Department of Ophthalmology, Johns Hopkins University, Baltimore, Maryland, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|